M. Romano

A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial

Max C. Richardson, Jun Yu Li, Kelly A. Fusco, 2022, Critical Care.

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial

Kelly A. Fusco, Maria Cristina Lopes, D. Devine, 2021, Nature Medicine.

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

Marcelo A. Falappa, Tariq M. Alhawassi, A. Laupacis, 2021, BMJ.

Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial

Max C. Richardson, Kelly A. Fusco, Troy H. Campbell, 2022, Intensive Care Medicine.

The association of low birthweight and prematurity on outcomes in children and adults with nephrotic syndrome—a NEPTUNE cohort study

N. Rogers, J. Lieske, M. Kretzler, 2023, Pediatric nephrology (Berlin, West).

Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis

Kelly A. Fusco, L. Forni, S. Bagshaw, 2024, Critical care explorations.

Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial

Kelly A. Fusco, L. Forni, S. Bagshaw, 2023, Intensive Care Medicine.